Gorgulho, Joao
Loosen, Sven H.
Masood, Ramsha
Giehren, Franziska
Pagani, Francesca
Buescher, Gustav
Kocheise, Lorenz
Joerg, Vincent
Schmidt, Constantin
Schulze, Kornelius
Roderburg, Christoph
Kinkel, Eva
Fritzsche, Britta
Wehmeyer, Simon
Schmidt, Benjamin
Kachel, Paul
Rolling, Christina
Götze, Julian
Busch, Alina
Sinn, Marianne
Pereira-Veiga, Thais
Wikman, Harriet
Geffken, Maria
Peine, Sven
Matschl, Urte
Altfeld, Markus
Huber, Samuel
Lohse, Ansgar W.
Beier, Fabian
Brümmendorf, Tim H.
Bokemeyer, Carsten
Luedde, Tom
von Felden, Johann
Funding for this research was provided by:
Deutsche Forschungsgemeinschaft (279874820)
Deutsche Forschungsgemeinschaft (461704932)
Deutsche Forschungsgemeinschaft (440603)
Bundesministerium für Bildung und Forschung (01EO2106)
Deutsche Krebshilfe (70114893)
Wilhelm Sander-Stiftung
European Research Council (771083)
UNIVERSITY CANCER CENTER HAMBURG
Universitätsklinikum Hamburg-Eppendorf (UKE)
Article History
Received: 6 July 2024
Accepted: 23 October 2024
First Online: 8 November 2024
Declarations
:
: The study protocol was approved by the ethics committee of the University Hospital RWTH Aachen, Germany (EK 206/09) and by the local ethics board in Hamburg “Ethik-Kommission der Ärztekammer Hamburg” (PV3578, PV5119, and PV4767) and conducted in accordance with the ethical standards laid down in the 1964 Declaration of Helsinki and its later amendments. Written informed consent was obtained from the patients.
: Not applicable.
: JvF has received honoraria from Roche and AstraZeneca. Further authors declare no conflict of interest.